{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-024632","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.786459+00:00","generated_at":"2026-06-01T02:49:13.476143+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Propanc Biopharma raises $41K via convertible note with 35% discount conversion","bullets":["Issued $49,200 convertible promissory note to 1800 Diagonal Lending LLC for $41,000, net proceeds for working capital.","Note bears 15% one-time interest, maturity April 15, 2025, with five scheduled payments totaling $56,580.","Conversion price set at 65% of lowest trading price over 10 prior trading days (35% discount) upon event of default.","Investor is accredited; note issued under Section 4(a)(2) and Regulation D exemption."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-024632","json":"https://secwatch.observer/filing/0001493152-24-024632.json","markdown":"https://secwatch.observer/filing/0001493152-24-024632.md","text":"https://secwatch.observer/filing/0001493152-24-024632.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224024632/0001493152-24-024632-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315224024632/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:49:13.476143+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}